Henk (H.) Schonewille PhD
Medical chemical technician, Transfusion Medicine
‘Red blood cell alloimmunization after blood transfusion’
Promotor: Prof A Brand
16 January 2008 - University of Leiden
Red blood cell (RBC) alloimmunization is a frequent complication of blood transfusions and can hamper optimal transfusion support. The aim of the research-line is to identify relevant factors which may help to predict which recipients will become (multi-)immunized after RBC transfusion and for whom extended matching between donor and patient is cost-effective. Our studies focus on the epidemiology of alloimmunization, the relation with antigens on other blood cells and genetic factors involved in the immune response.
- Clinical studies
|2014-present||Post-doc fellow Dept of Experimental Immunohematology, Sanquin Research|
|2008-2014||PhD Medicine (University of Leiden)|
|2008||Researcher at the Dept of Transfusion Medicine, Sanquin Research, Leiden|
Schonewille H, van Zijl AM, Wijermans PW. The importance of antibodies against low incidence red blood cell antigens in complete and abbreviated crossmatching. Transfusion 2003; 43:939-44.
Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000; 40:1127-31.
Schonewille H, Haak HL, van Zijl AM. Alloimmunization after blood transfusion in patients with hematologic and oncologic diseases. Transfusion 1999; 39:763-71.
Schonewille H, Haak HL, Kerkhofs H, Gerrits WBJ. The effect of anticoagulants on the size of platelets in blood smears in the course of time. Clin Lab Haemat. 1991; 13:67-74.
Haak HL, Kerkhofs H, van de Linden JSM, Schonewille H, Gonggrijp van der Sanden-van der Meer HS, Hermans J. Significance of in vitro cultures in myelodysplastic syndromes. Scand J Haematol 1986;.37:380-9.